Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Anacor Pharma Prices Public Offering Of 3.13 Mln Shares At $6.39/shr

RELATED NEWS
Trade ANAC now with 

Anacor Pharmaceuticals (ANAC: Quote) announced that it has priced an underwritten public offering of 3.13 million shares of its common stock at a price to the public of $6.39 per share for gross proceeds of $20.0 million.

Anacor has also granted the underwriters a 30-day option to purchase up to 15 percent of the shares of common stock offered in the public offering to cover over-allotments.

The company said it expects to use the net proceeds from the sale of the shares for research and development activities, working capital and general corporate purposes. All of the shares in the offering will be sold by Anacor. The offering is expected to close on May 1, 2013, subject to satisfaction of customary closing conditions.

Cowen and Company, LLC is acting as the sole book-running manager for the offering. Canaccord Genuity Inc. and Wedbush Securities Inc. are acting as co-managers for the offering.

Click here to receive FREE breaking news email alerts for Anacor Pharmaceuticals, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After trending higher over the past several sessions, stocks showed a lack of direction throughout the trading day on Friday before closing roughly flat. A muted reaction to a highly anticipated speech by Federal Reserve Chair Janet Yellen contributed to the lackluster performance. Republican Scott Brown has significantly narrowed the gap in the race against incumbent New Hampshire Sen. Jeanne Shaheen, D-N.H., according to the results of a new WMUR Granite State Poll. On the heels of the violent clashes between local police and protestors in Ferguson, Missouri, Sen. Claire McCaskill, D-Mo., announced that she will hold a Senate hearing in September to examine the militarization of local police departments.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.